Skip to main content

Apyx Medical Corp

For the period ended Sep 30, 2026. Filed Nov 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 5, 2026

APYX$2.93-4.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Table of Contents

INDEX TO QUARTERLY REPORT ON FORM 10-Q

For the quarterly period ended September 30, 2026

Page
Part I.Financial Information2
Item 1.Condensed Consolidated Financial Statements (Unaudited)2
Condensed Consolidated Balance Sheets at September 30, 2026 and December 31, 20252
Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2026 and 20253
Condensed Consolidated Statements of Changes in Equity for the three and nine months ended September 30, 2026 and 20254
Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 20255
Notes to Condensed Consolidated Financial Statements6
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations16
Item 3.Quantitative and Qualitative Disclosures about Market Risk24
Item 4.Controls and Procedures24
Part II.Other Information25
Item 1.Legal Proceedings25
Item 1A.Risk Factors25
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds25
Item 3.Defaults Upon Senior Securities25
Item 4.Mine Safety Disclosures25
Item 5.Other Information25
Item 6.Exhibits26
Signatures27
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.